Svb Financial Group
Latest statistics and disclosures from Svb Financial Group's latest quarterly 13F-HR filing:
- Top 5 stock holdings are COIN, ROOT, OKTA, AXSM, GPCR, and represent 91.42% of Svb Financial Group's stock portfolio.
- Added to shares of these 1 stock: Skillz.
- Reduced shares in these 7 stocks: OKTA, Dice Therapeutics, Pardes Biosciences, ALVR, GBIO, ELDN, Greenlight Biosciencs Hlds Pbc.
- Sold out of its positions in Dice Therapeutics, Greenlight Biosciencs Hlds Pbc, Pardes Biosciences.
- Svb Financial Group was a net seller of stock by $-2.8M.
- Svb Financial Group has $53M in assets under management (AUM), dropping by 0.47%.
- Central Index Key (CIK): 0000719739
Tip: Access up to 7 years of quarterly data
Positions held by Svb Financial Group consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Portfolio Holdings for Svb Financial Group
Svb Financial Group holds 21 positions in its portfolio as reported in the September 2023 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price | |
|---|---|---|---|---|---|---|
| Coinbase Global Com Cl A (COIN) | 57.5 | $31M | 407k | 75.08 |
|
|
| Root Cl A (ROOT) | 14.0 | $7.4M | 783k | 9.51 |
|
|
| Okta Cl A (OKTA) | 12.1 | $6.5M | -20% | 79k | 81.51 |
|
| Axsome Therapeutics (AXSM) | 4.5 | $2.4M | 34k | 69.89 |
|
|
| Structure Therapeutics Sponsored Ads (GPCR) | 3.4 | $1.8M | 35k | 50.42 |
|
|
| Health Sciences Acq Corp 2 (OBIO) | 2.1 | $1.1M | 127k | 8.72 |
|
|
| Moonlake Immunothe Rapeutics Clas S A Ord (MLTX) | 1.7 | $922k | 16k | 57.00 |
|
|
| Rover Group Com Cl A | 1.2 | $661k | 106k | 6.26 |
|
|
| Caremax Com Cl A | 1.2 | $636k | 300k | 2.12 |
|
|
| Planet Labs Pbc Com Cl A (PL) | 0.8 | $448k | 172k | 2.60 |
|
|
| Global E Online SHS (GLBE) | 0.4 | $203k | 5.1k | 39.74 |
|
|
| Cullinan Oncology (CGEM) | 0.2 | $122k | 14k | 9.05 |
|
|
| Caribou Biosciences (CRBU) | 0.2 | $99k | 21k | 4.78 |
|
|
| Generation Bio (GBIO) | 0.2 | $95k | -10% | 25k | 3.79 |
|
| Pacific Biosciences of California (PACB) | 0.2 | $86k | 10k | 8.35 |
|
|
| Skillz | 0.1 | $71k | 14k | 5.10 |
|
|
| Allovir (ALVR) | 0.1 | $37k | -33% | 17k | 2.15 |
|
| Movella Holdings (MVLA) | 0.1 | $30k | 56k | 0.54 |
|
|
| Venus Concept | 0.0 | $21k | 11k | 1.96 |
|
|
| Eledon Pharmaceuticals (ELDN) | 0.0 | $19k | -25% | 14k | 1.37 |
|
| Aeroclean Technologies | 0.0 | $3.1k | 21k | 0.14 |
|
Past Filings by Svb Financial Group
SEC 13F filings are viewable for Svb Financial Group going back to 2022
- Svb Financial Group 2023 Q3 filed Nov. 14, 2023
- Svb Financial Group 2023 Q2 filed Aug. 11, 2023
- Svb Financial Group 2023 Q1 filed May 15, 2023
- Svb Financial Group 2022 Q4 filed Feb. 14, 2023